NEGATIVE SKIN TEST CONTROL - GLYCERIN 50 %
GLYCERINE : 50 % · DIN 02426773 · JUBILANT HOLLISTERSTIER LLC
Health Canada status: MARKETED
What is NEGATIVE SKIN TEST CONTROL - GLYCERIN?
NEGATIVE SKIN TEST CONTROL - GLYCERIN 50 % contains GLYCERINE : 50 %. It is listed in the Health Canada Drug Product Database under DIN 02426773, held by JUBILANT HOLLISTERSTIER LLC, supplied as LIQUID for PERCUTANEOUS administration. Health Canada currently lists it as marketed, status dated 24-Jul-2026. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02426773 |
|---|---|
| Brand name | NEGATIVE SKIN TEST CONTROL - GLYCERIN |
| Generic / active ingredient | GLYCERINE : 50 % |
| Manufacturer | JUBILANT HOLLISTERSTIER LLC |
| Strength | 50 % |
| Dosage form | LIQUID |
| Route of administration | PERCUTANEOUS |
| Schedule | Ethical |
| ATC code | V04CL TESTS FOR ALLERGIC DISEASES |
| AHFS class | 36:89.00* ; See footnote |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 24-Jul-2026 |
What can be used instead?
Other Canadian products sharing ATC code V04CL TESTS FOR ALLERGIC DISEASES. 8 of 10 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| HISTATROL | 0.275 MG | SOLUTION | ALK-ABELLO INC | MARKETED | DIN 00609706 |
| HISTATROL | 2.75 MG | SOLUTION | ALK-ABELLO INC | MARKETED | DIN 00609692 |
| POSITIVE SKIN TEST CONTROL-HISTAMINE | 6 MG | SOLUTION | JUBILANT HOLLISTERSTIER LLC | MARKETED | DIN 02439514 |
| TOPICAL HAPTEN GEL | 100 % | GEL | DORMER LABORATORIES INC. | MARKETED | DIN 02466333 |
| TOPICAL HAPTEN GEL | 50 % | GEL | DORMER LABORATORIES INC. | MARKETED | DIN 02466325 |
| TOPICAL HAPTEN LIQUID | 100 % | LIQUID | DORMER LABORATORIES INC. | MARKETED | DIN 02466368 |
| TOPICAL HAPTEN LIQUID | 20 % | LIQUID | DORMER LABORATORIES INC. | MARKETED | DIN 02466341 |
| ALLERGY CANADA ALLERGEN EXTRACT - DIAGNOSTIC | 0 UNIT | SOLUTION | ALLERGY CANADA LTD | DORMANT | DIN 02242717 |
| TRUE TEST | 0.0065 MG | PATCH | MEKOS LABORATORIES APS | CANCELLED POST MARKET | DIN 02271885 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.